Vaqta Adult is a medicine containing the active ingredient(s) hepatitis a vaccine. On this page you will find out more about Vaqta Adult, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: hepatitis a vaccine
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Vaqta Adult 50 units/mL injection suspension, 1 mL vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
VAQTA is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus in persons 12 months of age and older. Primary immunisation should be given at least 2 weeks prior to expected exposure to Hepatitis A virus. Individuals who are or will be increased risk of infection include: Travellers to areas of intermediate or high endemicity for hepatitis A. Persons for whom Hepatitis A is an occupational hazard. Employee of child day-care centers. Certain institutional workers (eg. caretakers for the intellectually disabled). Health workers and teachers in remote Aboriginal and Torres Strait Islander communities. Nursing staff and other health care workers in contact with patients in paediatric wards and infectious disease wards. Sewerage workers. Recipients of blood products. Individuals with chronic liver disease and those who have had a liver transplant. Homosexually active males. Human Immunodeficiency Virus (HIV)-infected Adults.
Table of characteristics
|Visual appearance||Slightly opaque white suspension.|
|Route of administration||Intramuscular|
1mL: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Do not Freeze|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
VAQTA Paediatric/adolescent Formulation Suspension for injection - myDr.com.au
VAQTA Paediatric/adolescent Formulation Suspension for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results